Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Appistry
AddedFeb 15, 2024
UpdatedJun 18, 2026
Appistry

Appistry

Series A

Appistry: Cloud solutions for clinical labs and hospitals, optimizing genomics data.

HQ
St. Louis, MO, US
Founded
2001
Overview
Compare
Fundraising
Employees

Founded in 2001, Appistry is dedicated to providing cloud solutions for clinical labs, research institutions, and hospitals. The company's core mission is to enable healthcare organizations to effectively utilize genomics data, enhancing precision medicine and patient care. Appistry offers a suite of products and services designed to optimize the management, analysis, and interpretation of complex genomic information, focusing on improving clinical outcomes and operational efficiency.

Notable affiliated individuals include the founders and key investors who have supported Appistry's growth and innovation in the healthcare technology sector. The company has achieved significant milestones, such as developing robust cloud-based platforms that streamline genomic data processing. Appistry's impact is evident in its contribution to advancing personalized medicine, helping medical professionals make more informed decisions based on comprehensive genomic insights.

Appistry - Similar Companies

Appgenesys logo

Appgenesys

Aplicor logo

Aplicor

Nest Genomics logo

Nest Genomics

nestgenomics.com

Station X logo

Station X

Basepair logo

Basepair

basepairtech.com

Dnanexus logo

Dnanexus

dnanexus.com

Appedo logo

Appedo

appLariat logo

appLariat

applariat.com

MyCancerDB logo

MyCancerDB

ennov1.com

Era7 Bioinformatics logo

Era7 Bioinformatics

Geneformics logo

Geneformics

Ovation logo

Ovation

ovation.io

Seven Bridges logo

Seven Bridges

sevenbridges.com

GenomOncology logo

GenomOncology

genomoncology.com

AppwoRx logo

AppwoRx

myappworx.com

Appistry - Quick Facts

Who are Appistry's competitors?

Companies similar to Appistry include Appgenesys, Aplicor, Nest Genomics and Station X.

When was Appistry founded?

Appistry was founded in 2001.

Where is Appistry's headquarters located?

Appistry's headquarters is located in St. Louis, MO, US.

When was Appistry's last funding round?

Appistry's most recent funding round was for $10.3M (USD) in February 2015.

How much has Appistry raised to-date?

As of Feb 20, 2015, Appistry has raised a total of $52.5M (USD).

How many employees does Appistry have?

Appistry has 11 employees as of Feb 5, 2024.

Appistry - Classification

Ownership
  • Equity
Technology
  • Analytics
Geographic Exposure
  • Global
Model
  • Platform
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Cloud Solutions
Tags
  • Cloud
  • Healthcare
  • Healthtech
  • SaaS
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541500Computer Systems Design and Related Services
  • 541000Professional, Scientific, and Technical Services
  • 541510Computer Systems Design and Related Services
  • 541511Custom Computer Programming Services
SIC
  • 7300Business Services
  • 7370Computer Programming, Data Processing, And Other Computer Related
  • 7371Computer Programming Services
Show 5 more industry codes
NAICS
  • 513200Software Publishers
  • 510000Information
  • 513000Publishing Industries
  • 513210Software Publishers
SIC
  • 7372Prepackaged Software